Skip to content

Technology
PIpeline
- Intranasal Naloxone
- Intranasal Epinephrine
About us
Contact
News
Investors

Technology
PIpeline
- Intranasal Naloxone
- Intranasal Epinephrine
About us
Contact
News
Investors

Press Releases

Choose Year
Search Press Releases

Found 9 Results

April 13, 2021

Nasus Pharma announces positive Results in Naloxone Pivotal Trial.

«12

IR Contact

Mike Moyer
LifeSci Advisors
617-308-4306
mmoyer@lifesciadvisors.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

Home
About us
Technology
Pipeline
Contact us

Investors Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
Investor FAQs

Privacy policy
Cookies policy
Terms And Conditions Of Use

© 2025 Nasus Pharma All rights reserved

Scroll to Top